Not really. Unfortunately a buyout would cost another company, at bare minimum, 103 million with the market cap. The downside to that company that would buy them, is that YGYI made negative income of 430,000 last year, and this past quarter only about 1 million. Therefore, at a 103+ mil buyout, the buying company (at this rate) would have to wait about 25 years just to get that income back, or based on the year income, they'd never get it back. There's too much discrepancy in the numbers for it to be a SAFE bet that another company would buy them. That doesn't mean, however, that it couldn't happen. Another company might see something about YGYI that is easily fixable, but a conversative company would most likely stay away.
LOL. I have been preaching this same thing for 4 years. CBIS IS a scam, but know what? I still invest in it. It is one of the most well known scam stocks out there, but people buy it all the time due to hype, etc. It's a wonderful stock, because if you play cards right, you make bank. They dillute like it's their job, and each time they do, they pump like crazy. I just bought back into this stock yesterday. Although I feel it will still go down to .036 first, I feel I can at least make a good 20% on it no problem on the next pump. Many people don't invest here because they believe in the company, only a few on this board do. Otherwise, most well know that this company means nothing.
You probably have the ability to do market order or stop limit order. I unfortunately do not as I am cheap and don't like to pay for the more expensive platforms. Nonetheless, I changed my order to execute at .19. I'm all in, hello to everybody again :)
Can be one of several things, but it's definitely revolving around technical trades. Same thing happened to YMI well before they were bought out by GMCR. A spike is hit after a series of PR pumps (regardless of validity), then traders bring it down based on rules such as fibonacci retracement, support/resistance points, etc. It's a biotech, all of them go through this. It's unfortunate but it's life
TBH, INO's main claim is their DNA vaccine, but there has yet to be a successful DNA vaccine that made it through all the FDA trials. It's promising but historically risky. More focus if anything, should be placed on their other products.
No one knows for sure, but much of the consensus seems to be that they might have had a large deposit after the possible of increase of 2 bil to 4 bil authorized shares and are now being investigated since there doesnt seem to have been an advance notice as there typically is